BACKGROUND: Fine-needle aspiration (FNA) biopsy is an accurate method for the diagnosis of solid pancreatic masses.
INTRODUCTION
Pancreatic exocrine carcinoma, typically a ductal adenocarcinoma, already is among the deadliest cancers to affect humans, and the disease burden is expected to worsen such that it likely will be the second leading cause of cancer death in United States within a few years. [1] [2] [3] Several challenges impede the effective management and treatment of this disease, including late diagnosis. 1 Although a considerable amount of research has focused on pancreatic cancer, including on enhanced detection methods, this has not led to a significant change in prognosis. 4 In recent years, there has been a surge of interesting developments, including monitoring of carbohydrate antigen 19-9 (CA 19-9) levels 5 and the detection of microRNA markers in peripheral blood, 6 that hold the promise of improved outcomes. However, these still require additional research and validation. Thus, the detection of pancreatic cancer currently relies on a combination of imaging methodologies and biopsy diagnosis [7] [8] [9] and, among the different modalities, endoscopic ultrasound (EUS)-guided biopsy and brush cytology of the pancreaticobiliary ducts are the standard of care for diagnosis. [10] [11] [12] EUS uses a transducer fitted on an endoscope to evaluate gastrointestinal as well as para-gastrointestinal structures, such as the pancreas, using high-frequency ultrasonic waves. Although it is an effective tool for the detection of pancreaticobiliary lesions, 13, 14 it is limited in its ability to differentiate between benign and malignant lesions. 15 When performed by an experienced gastroenterologist and interpreted by an experienced cytopathologist, EUS-guided fine-needle aspiration (EUS-FNA) biopsies are not only the most commonly performed first step, but also are often the only necessary step required to achieve tissue diagnosis of solid pancreatic lesions. 16 A combination of architectural and cytologic abnormalities may be present in pancreaticobiliary carcinoma specimens; these include nuclear enlargement including anisonucleosis of at least 3 to 4 times within an epithelial cluster, disordered epithelial clusters with nuclear crowding, irregular nuclear contours including grooves, irregular chromatin distribution (ie, changes in nuclear chromasia), nucleoli, mitosis, and tumor diathesis. 7, 17, 18 Current evidence has demonstrated that EUS-FNA has a high degree of diagnostic accuracy, with a sensitivity of 92% and a specificity of 96%. 12, 19 However, this nevertheless translates into several missed cases or equivocal diagnoses.
20,21
The diagnostic category of "atypical cells" is especially problematic, with follow-up resections yielding both benign and malignant outcomes. 22 In the face of an atypical diagnosis, the decision-making process is guided by radiologic findings, including lesion size and relationship to adjacent anatomic structures, and clinical findings. 23 Computer-assisted diagnosis has been used to assist gastroenterologists in the EUS evaluation of pancreatic lesions with varying degrees of success. 24, 25 There also have been attempts to use multivariate models that combine EUS findings, clinical findings, and CA 19-9 levels to aid in the management of inconclusive cases. 26 Nevertheless, to our knowledge to date, there have been only limited attempts to integrate computer models into pancreatic cytologic diagnosis, which was our aim herein.
MATERIALS AND METHODS

Case Selection and Image Acquisition
The laboratory information system was queried for pancreatic FNA specimens accessioned between January 2010 and July 2017. All ThinPrep (Hologic Inc, Marlborough, Massachusetts) slides that included at least 1 cluster of cells were included. Only cases categorized as "suspicious for malignancy," "positive for malignant cells," or "negative for malignant cells" were included for the training set. The cases categorized as "atypical cells present" all were restricted to the test set. All nondiagnostic samples were excluded. Overall, 75 samples were analyzed (20 malignant and suspicious cases, 24 benign cases, and 31 atypical cases). High-resolution, 16-bit images of all the epithelial clusters from each slide were obtained at an original magnification of 3400 using an Olympus DP73 camera (Olympus Corporation, Center Valley, Pennsylvania) mounted on an Olympus microscope (BX40 model) and stored as *.TIFF files. A cluster was defined as any group of 5 epithelial cells. The images then were filtered by the cytopathologist, and only images of clusters that were representative of the diagnosis of the case were included in the final data sets (eg, when both benign and malignant cell clusters were present in a single sample, the former were excluded). In total, 277 images were available for analysis after filtering (118 benign, 74 malignant, and 85 atypical).
The following steps all were performed using MAT-LAB (version 8.2, release R2013b; MathWorks, Natick, Massachusetts).
Preprocessing
All images were transformed into grayscale. Because digital image acquisition leads to a degree of noise accumulation in the images, 2-dimensional adaptive noise-removal filtering was applied to reduce the background noise. 27 Bimodal size distribution thresholding was performed to filter out objects present in the images that were smaller than a set threshold (ie, single cells and debris), and the background was inverted (ie, white to black).
Nuclear Segmentation
We used a hierarchical K-means clustering algorithm for the extraction of the regions of interest (ROIs) (ie, nuclear and subnuclear features). 28 This method uses pixel intensity values and Euclidean distance to group the data into a fixed number of clusters, such that the pixels are clustered around centroids with each centroid being the mean of all pixels. 29 In brief, the process starts with the computation of the intensity histogram of an image, followed by assignment of centroids using K random intensities. This process is reiterated until cluster labels do not change from one
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iteration to the next. 30 Based on Euclidean distance from the final centroids, similar clusters of pixels (ie, ROI) are identified ( Fig. 1 ).
Feature Extraction
A set of features was extracted from each of the ROIs. The features extracted included contour, interior, perimeter, area, minimum intensity, maximum intensity, mean intensity, and mean intensity standard deviation (SD). These features are proxies for the basic cytomorphologic features assessed in pancreatic FNA specimens, namely nuclear size, shape, and chromasia. 7, 18, 20 Univariate and Multivariate Analyses
The extracted features were compared between the benign and malignant groups using the Mann-Whitney U test.
Due to simplicity of linear models, we first used binary logistic regression to perform a multivariate analysis between benign and malignant images. The accuracies of all the models' predictions were assessed using area under curve (AUC) and R-squared statistics.
Multilayer Perceptron Neural Network
The extracted features were fed as input vectors into a multilayer perceptron. The multilayer perceptron is a feedforward, nonlinear neural network. This model first was trained to make decisions regarding the presence of malignant cells at the individual ROI level. The decisions made at the ROI level then were fed to a second multilayer perceptron that assessed benign versus malignant at the image level. 31 Approximately 70% of the data were used for training the multilayer perceptron neural network (MNN), and the remainder were used as a test set. With the exception of the atypical cases, which all were assigned to the test set, the allocation of cases between the test set and training set was performed randomly.
Survival Analysis
To determine the efficacy of the MNN in the diagnosis of atypical pancreatic FNAs, a survival analysis was conducted. Follow-up data were extracted from hospital records, and a failure event was defined as either all-cause mortality or the confirmed diagnosis of pancreatic adenocarcinoma with the survival duration recorded as the number of days to failure event. For the atypical cases, if any of the clusters from a case was diagnosed as "malignant" by the MNN, then the case was considered malignant. The log-rank test and Kaplan-Meier estimator were used to compare the survival between the atypical cases diagnosed as malignant and the atypical cases diagnosed as benign by the MNN.
RESULTS
We extracted 277 images of cell clusters from 75 cases. Excluding the atypical images, the MNN was 83.9% accurate (AUC, 0.917) when evaluating the test data set for individual ROIs (Fig. 2) . The average pseudoprobability for rendering a diagnosis of benign for an ROI belonging to a benign image was 73.23% (SD, 24.95) and the average pseudoprobability for rendering a diagnosis of malignant for an ROI belonging to a malignant image was 78.41% (SD, 22.94). However, evaluation of the test data set at the image level by the MNN was 100% accurate. If 55.1% of ROIs in an image were determined to be malignant, the model invariably returned a diagnosis of malignant for the image.
Of the 31 atypical cases, a total of 15 cases later were shown to have pancreatic carcinoma (either through subsequent pathology evaluation or chart review); the MNN correctly assigned a diagnosis of malignant to 12 of these cases (sensitivity of 80%). For the remaining 16 atypical cases, a diagnosis of pancreatic carcinoma could not be established (average follow-up, 255 days). The MNN diagnosed 12 of these cases as benign and 4 as malignant (specificity of 75%).
The log-rank test demonstrated that the atypical cases that were diagnosed as benign by the MNN had a better outcome (ie, no death or confirmed diagnosis of pancreatic cancer) (median time to diagnosis of cancer or death, 1174 days) compared with the atypical cases that were diagnosed as malignant by the MNN (median time to diagnosis of cancer or death, 67 days) (P 5 .046). The Kaplan-Meier estimator for these results is shown in Figure 3 .
DISCUSSION
The diagnosis of pancreaticobiliary cytology specimens can be challenging, especially given that carcinomas can be well differentiated and that differentiation from reactive (ie, benign) epithelial atypia is a looming concern. 22, 32 Despite this, EUS-guided biopsy has been shown to be an accurate method for the diagnosis of carcinoma, 33 and presently is considered to be the best diagnostic tool in the evaluation of pancreatic lesions. Computer-Assisted Cytologic Diagnosis in Pancreatic FNA/Momeni-Boroujeni et al
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Cytopathologists consider different cytomorphologic features when evaluating FNA samples for pancreaticobiliary cancer, including: 1) cellularity; 2) cell type (eg, carcinomas typically are ductal-type adenocarcinomas with columnar morphology); and 3) cytologic/nuclear abnormalities, including nuclear disorder within clusters and the presence or absence of single abnormal cells. The latter set of features in particular is used to distinguish adenocarcinoma from nonneoplastic pancreaticobiliary epithelium or, more often, from nonneoplastic gastrointestinal lining epithelium, which contaminates the sample. Subsequently, samples are categorized as "nondiagnostic," "negative for malignant cells," "atypical cells present," "suspicious for malignancy," or "positive for malignant cells." In well-differentiated adenocarcinomas, cytomorphologic changes are subtle, with anisonucleosis taking on particular importance as well as comparison of putative carcinoma clusters with the often present (and helpful) nonneoplastic contaminant. 17, 34 A major challenge is the atypical diagnostic category. Follow-up studies have shown that these atypical cells ultimately may represent either benign or malignant pathology; for example, Alston et al demonstrated that approximately 55% of atypical EUS-FNA specimens were neoplastic on follow-up, and they proposed using a predictive model that includes clinical and radiologic findings to improve the accuracy of EUS-FNA diagnosis and subsequent patient management. 35 Computer screening systems already have been introduced to the practice of cytology, with commercial systems approved by the US Food and Drug Administration currently available. These focus on the screening of Papanicolaou tests, and they either identify pertinent fields in a slide for human review or provide a probability of abnormal findings on the slide, effectively screening out slides without abnormal cytology. 36 Such systems fall under the umbrella term "image cytometry," which is the evaluation of cytomorphologic features using computerized systems to acquire, process, segment, extract (ie, quantify), and analyze features of interest from digital images. 36 Image cytometry allows for reproducible and objective feature measurements that can assist in improving diagnostic accuracy. 37 To the best of our knowledge, the majority of image cytometry applications in cytopathology to date have focused on extracting nuclear features related to DNA content and chromatin distribution. 38 Over the past decade, different groups have applied image cytometry to the diagnosis of pancreatic cytology specimens. Biesterfeld and Deacu used DNA image cytometry to measure the DNA content of pancreatic cells on cytology smears and were able to attain a sensitivity of 87% and a specificity of 95% for the diagnosis of pancreatic malignant lesions. 39 In surgical specimens, image analysis by neural networks has been described. Okon et al used neural networks for the classification of pancreatic intraductal lesions by extracting nuclear features, especially chromatin texture, and were able to attain a correct nuclear classification rate of 73%. 40 In the current study, we describe a unique diagnostic application of image cytometry. We used hierarchical Kmeans clustering to segment images of cell clusters taken from pancreatic FNA cytology slides into nuclear and subnuclear ROIs and then trained an MNN to distinguish between benign and malignant cells using extracted features that parallel those used by cytopathologists in diagnosis. Linear classification using these features demonstrated considerable overlap, especially at the level of the individual cell (ie, ROI). The accuracy of the MNN without and with atypicals was 100% and 90.6%, respectively. The MNN is at least as accurate as the cytopathologist who originally reviewed the slides. In fact, because the original cytopathology diagnoses were not made at the image (ie, cell cluster) level, but rather at the case level (ie, taking into account all the images of each case to reach a single diagnosis), the MNN actually may prove to be more accurate than traditional cytomorphologic analysis. Considering this fact along with the finding that the predictions of the MNN model demonstrated a sensitivity of 80% for atypical cases, this model certainly holds the potential to be used as a screening tool for pancreatic FNA specimens.
One limitation of the current study was the number of cases used (75 cases). However, the large total number of images (277 cases) greatly offsets this limitation. In addition, well-differentiated adenocarcinomas may have been somewhat underrepresented in the current study sample, in part because these are, at times, classified as atypical rather than suspicious or positive due to their morphologic subtlety. Of course, herein lies the potential value of image cytometry with MNNs for such specimens because the atypical results often are not followed by prompt definitive intervention (eg, surgery) due to uncertainty regarding the likelihood of carcinoma. The results of the current study demonstrate that evaluation of atypical cases using the MNN can be a helpful tool because there is a clear survival advantage for atypical cases that are diagnosed as benign by MNNs, with a sensitivity and specificity of 80% and 75%, respectively. This translates into a significant positive likelihood ratio of 3.2, which would considerably increase the posttest probability of malignancy after an MNN malignant, atypical cytology case. Such an application of MNNs to atypical cases would be expected to greatly help clinicians and patients in making their decisions regarding who will need further diagnostic workup before definitive medical or surgical intervention. However, further study is paramount to confirm the accuracy of our approach. If the results of the current study are reproduced at a larger scale for atypical cases, computer-assisted diagnosis in pancreaticobiliary specimens might be used routinely for these equivocal cases and has the potential to greatly enhance decision making, shorten the time to diagnosis and improve treatment outcomes for patients with this aggressive malignancy.
The results of the current study demonstrate that image cytometry models have the potential to become great tools in nongynecologic cytopathology, either through feature extraction, quantitation, and analysis by linear modeling or through the application of deep learning algorithms and probability assignment. Furthermore, because image cytometry uses without compromising the existing slide-based diagnostic material, it can be applied easily, unlike other potential ancillary tests such as immunohistochemistry, fluorescence in situ hybridization, or molecular studies that require the use of often limited and perhaps unavailable additional material. We expect that with further development, including training and testing of the model on a larger and more comprehensive data set, this methodology could be used routinely for both atypical and suspicious FNA specimens and, especially for the former, there is the potential for a great impact on patient care, particularly on morbidity and mortality, due to earlier definitive diagnosis and intervention.
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